.cd19-targeted-therapy #Infection-Rates #jumplink-image .component-content {
    padding-left: 5px;
    padding-right: 28px;
}

.cd19-targeted-therapy #banner-promo .banner-div {
    justify-content: space-between;
    align-items: center;
}

.cd19-targeted-therapy #banner-promo .banner-div h1 {
    width: 100%;
    max-width: 500px;
    font-weight: 700;
}

.cd19-targeted-therapy #banner-promo .banner-div .top-grey-text {
    font-weight: 700;
}

#safety-adverse-events #prescribing-uplizna h2.sub-heading {
    margin-bottom: 0;
    font-size: 24px;
    font-family: 'Arial-Bold', sans-serif;
}

.cd19-targeted-therapy #banner-promo .banner-div>div:last-child .avatar-details .avatar-name,
.cd19-targeted-therapy #banner-promo .banner-div>div:last-child .avatar-details .avatar-desc {
    color: #000;
}

.cd19-targeted-therapy #banner-promo .banner-div>div:last-child .avatar-details .avatar-desc {
    font-family: "Arial";
    font-size: 16px;
    line-height: 24px;
}

.cd19-targeted-therapy #banner-promo .banner-div>div:last-child {
    width: 501px;
}

.cd19-targeted-therapy #banner-promo .banner-div>div:last-child .avatar-details {
    width: unset;
}

#safety-adverse-events #uplizna-rituximab-data #infection-rates-text h2.infection-rates {
    margin-bottom: 24px;
}

body.cd19-targeted-therapy#safety-adverse-events #aar-patients {
    margin: 0px 0 24px 0;
}

.cd19-targeted-therapy #uplizna-rituximab-data .plain-html p.first-p-tag,
.cd19-targeted-therapy #uplizna-rituximab-data .plain-html p.second-p-tag {
    font-size: 18px;
}

body.cd19-targeted-therapy div#infection-rates-text .component-content .Patients {
    max-width: 900px;
}

.cd19-targeted-therapy p.footnotes-txt.second-p-tag.third-tag {
    margin-bottom: 28px;
}

#safety-adverse-events #tabs-links li a {
    padding-inline: 45px;
}

.cd19-targeted-therapy #uplizna-rituximab-data.col-xl-12 .component-content>p {
    padding-inline: 0;
}

body.cd19-targeted-therapy#safety-adverse-events #uplizna-rituximab-data .plain-html:last-child p.second-p-tag.com-indent,
.cd19-targeted-therapy #uplizna-rituximab-data.col-xl-12 .component-content>p.second-p-tags {
    padding-left: 5px;
}

.cd19-targeted-therapy #uplizna-rituximab-data .plain-html:last-child p.first-p-tag,
.cd19-targeted-therapy.bodyclass #uplizna-rituximab-data .plain-html:last-child p.first-p-tag,
#uplizna-rituximab-data .component-content p.first-p-tags {
    font-family: 'Arial-Bold';
}

body.cd19-targeted-therapy #Infection-Rates #page-code-text {
    margin-bottom: 0px;
}

body.cd19-targeted-therapy#safety-adverse-events #uplizna-rituximab-data .plain-html:last-child p.second-p-tag {
    padding-top: 0px;
    padding-left: 0;
}

#uplizna-rituximab-data p.footnotes-txt.second-p-tag.third-tag {
    text-indent: initial !important;
}

body.cd19-targeted-therapy#safety-adverse-events #uplizna-rituximab-data .plain-html h2::before {
    background: unset;
}

body.cd19-targeted-therapy#safety-adverse-events #aar-patients {
    margin: 0px 0 25px 0;
}

body.cd19-targeted-therapy .plain-html h1 {
    color: #333F48;

    font-family: Arial;
    font-size: 28.929px;
    font-style: normal;
    font-weight: 700;
    line-height: normal;
}

.cd19-targeted-therapy.upliznahcpNmosd-redesign #uplizna-rituximab-data p {
    font-size: 16px !important;
    line-height: 1.2;
}

.cd19-targeted-therapy #aar-patients:not(:has(#aar-patients-image)) .component-content {
    max-width: 1185px;
}

.cd19-targeted-therapy #aar-mobile-show {
    display: none;
}

.cd19-targeted-therapy #aar-patients-image {
    display: block;
}

body.cd19-targeted-therapy div#infection-rates-text .component-content .Patients {
    color: var(--Dark-Violet, #823F98);
    /* Desktop/H1 */
    font-family: 'Arial-Bold';
    font-size: 36px;
    font-style: normal;
    font-weight: 700;
    line-height: 44px;
    margin-top: 50px;
}


@media(max-width:767px) {
    .cd19-targeted-therapy #aar-mobile-show {
        display: block;
    }

    body.cd19-targeted-therapy #celldepletion .mobile-content-new .first-p-tags,
    body.cd19-targeted-therapy #celldepletion .mobile-content-new .second-p-tags {
        color: #000;
        font-family: 'Arial-Bold';
        font-size: 18px;
        font-style: normal;
        font-weight: 700;
        line-height: 24px;
        padding-inline: 0;
    }

    body.cd19-targeted-therapy #celldepletion .mobile-content-new .second-p-tags {
        font-weight: 400;
        text-indent: -7px;
        padding-left: 7px;
        font-family: 'Arial';
        margin-block: 24px 32px;
    }

    body.cd19-targeted-therapy#safety-adverse-events #Bcelldepletion #aar-patients {
        padding-inline: 0;
    }

    #Bcelldepletion #aar-patients img {
        width: 100%;
    }


    body.cd19-targeted-therapy div#infection-rates-text .component-content .Patients,
    #infection-rates-text h2.infection-rates,
    #safety-adverse-events h2 {
        font-size: 30px;
        line-height: 38px;
    }

    .cd19-targeted-therapy #infection-rates-text h2.infection-rates,
    .cd19-targeted-therapy#safety-adverse-events h2,
    #few-patient-text .paragraph {
        padding-right: 0;
    }

    .cd19-targeted-therapy #B-Cell-Depletion,
    #uplizna-rituximab-data .component-content p.first-p-tags,
    #uplizna-rituximab-data .component-content p.second-p-tags {
        padding-inline: 15px;
    }

    .cd19-targeted-therapy #aar-patients-image {
        display: none;
    }

    .cd19-targeted-therapy #aar-patients:not(:has(#aar-patients-image)) .component-content,
    .cd19-targeted-therapy div#infection-rates-text .component-content .Patients {
        max-width: 100%;
    }

    .cd19-targeted-therapy #banner-promo .banner-div>div:last-child {
        width: 100%;
    }

    .cd19-targeted-therapy #banner-promo .banner-div {
        padding-inline: 0;
        gap: 32px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion {
        display: block;
        padding-inline: 15px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-header {
        background-color: #823F98;
        font-family: "Arial";
        font-size: 20px;
        font-style: normal;
        font-weight: 700;
        line-height: 28px;
        color: #fff !important;
    }

    .cd19-targeted-therapy .refrences-accordion .accordion .toggle-header {
        background: none;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .item .field-heading h3 {
        color: #fff;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content {
        background-color: #fff;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .item.active .toggle-header {
        background-color: #f5f5f6;

    }

    .cd19-targeted-therapy .accordion#mob-accordion .item.active .field-heading h3 {
        color: #823F98 !important;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content .field-content h4 {
        font-family: "Arial-Bold", sans-serif;
        font-size: 22px;
        font-style: normal;
        line-height: 30px;
        color: #2d2d2d;
        margin-bottom: 16px;
        padding-top: 16px;
        text-align: left;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content .tab-content img {
        margin-bottom: 32px;
        width: 100%;
        height: auto;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content .tab-content p {
        color: #000;
        font-family: "Arial";
        font-size: 18px;
        font-style: normal;
        font-weight: 400;
        line-height: 22px;
        font-weight: 700;
        margin-bottom: 16px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content .tab-content p.ft-4 {
        font-weight: 400;
        margin-bottom: 32px;
        text-indent: -6px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-content .field-content {
        padding-inline: 0px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .toggle-header .component.content.col-12 {
        padding-inline: 0;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .item .field-heading:after {
        content: "";
        background-image: url(/~/media/Themes/Horizon/Upliznahcp/Upliznahcp/Images/icons/patient-form-down-icon);
        width: 16px;
        height: 16px;
        background-repeat: no-repeat;
        top: 5px;
        position: absolute;
        right: 10px;
        background-size: contain;
        background-color: unset;
        min-width: 27px;
        min-height: 27px;
    }

    .cd19-targeted-therapy .accordion#mob-accordion .items>.item.active .field-heading:after {
        content: "";
        transform: rotate(0deg);
        background-image: url(/~/media/Themes/Horizon/Upliznahcp/Upliznahcp/Images/cd19-targeted-therapy/purple-up-arrow-mark.png);
        min-width: 27px;
        min-height: 27px;
    }


    .cd19-targeted-therapy .accordion#mob-accordion .item .field-heading h3 {
        position: relative;
        font-weight: 700;
        font-size: 20px;
        line-height: 28px;
        font-family: 'Arial';
    }

    .cd19-targeted-therapy #Infection-Rates #tabs-links,
    .cd19-targeted-therapy #jumplink-accordian-mob,
    .cd19-targeted-therapy #jumplink-image,
    .cd19-targeted-therapy #Infection-Rates .component.plain-html.col-xl-12#uplizna-rituximab-data {
        display: none;
    }

    .cd19-targeted-therapy #uplizna-rituximab-data h2.infection-rates#Annualized-Attack-Rate {
        margin-bottom: 24px;
    }

    .cd19-targeted-therapy #uplizna-rituximab-data .plain-html .component-content p.first-p-tag {
        padding-bottom: 24px;
        padding-top: 0px;
    }

    body.cd19-targeted-therapy div#infection-rates-text .component-content .Patients {
        margin-top: 32px;
        margin-bottom: 32px;
        padding-inline: 15px;
    }

    .cd19-targeted-therapy #uplizna-rituximab-data p.second-p-tag.third-tag {
        margin-bottom: 32px;
    }

}

.cd19-targeted-therapy .refrences-accordion .accordion {
    display: block;
}

@media(min-width:768px) {
    .cd19-targeted-therapy .accordion#mob-accordion {
        display: none;
    }
}